Anacor Pharmaceuticals (ANAC)
Add to Watchlists Create an Alert
5.49
-0.18 -3.17%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Anacor Pharmaceuticals News
Wider-Than-Expected Loss at Anacor - Analyst Blog
Zacks May 13Anacor Pharma reported first quarter 2013 net loss per share of 42 cents, wider than the Zacks Consensus Estimate of a loss of 34 cents
Anacor Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 10Anacor Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript
Anacor Pharmaceuticals, Inc. (ANAC) Posts Q1 Loss of 42c/Share
Street Insider May 9Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results
Business Wire May 9Anacor Pharmaceuticals announced today its financial results for the first quarter ended March 31, 2013.
Anacor Pharmaceuticals Announces First Quarter 2013 Financial Results Conference Call and Webcast
Business Wire May 7Anacor Pharmaceuticals will release its financial results for the first quarter ended March 31, 2013, on Thursday, May 9, 2013 at approximately 4:00 p.m. ET / 1:00 p.m.
Valeant Pharmaceuticals Agrees to Delay Efinconazole Launch
Benzinga May 2Valeant Pharmaceuticals Provides Efinconazole Update
CNW Group May 2Valeant Pharmaceuticals Provides Efinconazole Update
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ANAC | 5.49 | -0.18 | -3.17% | 197.95M |
New watchlist
